SCHEMBL2484548

SCHEMBL2484548

O=C(NS(=O)(=O)c1ccc(NC2CCN(C3CCOCC3)CC2)c([N+](=O)[O-])c1)c1ccccc1Oc1cccc2[nH]ccc12

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3419070 0.95 BCL2 (0.55) BCL2
SCHEMBL2507851 0.89 BCL2 (0.54) BCL2
SCHEMBL2499645 0.89 BCL2 (0.62) BCL2
SCHEMBL30314030 0.89 BCL2 (0.62) BCL2
SCHEMBL30314016 0.85 BCL2 (0.66) BCL2
SCHEMBL1958126 0.85 BCL2 (0.50) BCL2
SCHEMBL2503120 0.84 BCL2 (0.63) BCL2
SCHEMBL3398579 0.84 BCL2 (0.53) BCL2
SCHEMBL3395330 0.84 BCL2 (0.63) BCL2
SCHEMBL1954913 0.84 BCL2 (0.54) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376480-A2 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES Abbott Laboratories (US) 2011-10-19 EP disclosed
WO-2010065865-A2 BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-06-10 WO disclosed